Literature DB >> 27329556

Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.

Samantha E Yohn1, Emily E Errante1, Aaron Rosenbloom-Snow1, Matthew Somerville1, Margaret Rowland1, Kristin Tokarski1, Nadia Zafar1, Merce Correa2, John D Salamone3.   

Abstract

Deficits in behavioral activation, exertion of effort, and other psychomotor/motivational symptoms are frequently seen in people with depression and other disorders. Depressed people show a decision bias towards selection of low effort activities, and animal tests of effort-related decision making are being used as models of motivational dysfunctions seen in psychopathology. The present studies investigated the ability of drugs that block dopamine transport (DAT), norepinephrine transport (NET), and serotonin transport (SERT) to modulate work output in rats responding on a test of effort-related decision making (i.e., a progressive ratio (PROG)/chow feeding choice task). With this task, rats choose between working for a preferred food (high carbohydrate pellets) by lever pressing on a PROG schedule vs. obtaining a less preferred lab chow that is freely available in the chamber. The present studies focused on the effects of the selective DAT inhibitor GBR12909, the selective SERT inhibitor fluoxetine, and the selective NET inhibitors desipramine and atomoxetine. Acute and repeated administration of GBR12909 shifted choice behavior, increasing measures of PROG lever pressing but decreasing chow intake. In contrast, fluoxetine, desipramine and atomoxetine failed to increase lever pressing output, and actually decreased it at higher doses. In the behaviorally effective dose range, GBR12909 elevated extracellular dopamine levels in accumbens core as measured by microdialysis, but fluoxetine, desipramine and atomoxetine decreased extracellular dopamine. Thus, blockade of DAT increases selection of the high effort instrumental activity, while inhibition of SERT or NET does not. These results have implications for the use of monoamine uptake inhibitors for the treatment of effort-related psychiatric symptoms in humans.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Dopamine; Motivation; Norepinephrine; Serotonin; Transport

Mesh:

Substances:

Year:  2016        PMID: 27329556     DOI: 10.1016/j.neuropharm.2016.06.018

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  25 in total

1.  Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Authors:  Samantha E Yohn; Daniela Alberati; Merce Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2017-01-12       Impact factor: 4.530

2.  Inflammation-induced motivational changes: Perspective gained by evaluating positive and negative valence systems.

Authors:  Elisabeth G Vichaya; Robert Dantzer
Journal:  Curr Opin Behav Sci       Date:  2018-02-10

3.  An Interaction between Serotonin Receptor Signaling and Dopamine Enhances Goal-Directed Vigor and Persistence in Mice.

Authors:  Matthew R Bailey; Olivia Goldman; Estefanía P Bello; Muhammad O Chohan; Nuri Jeong; Vanessa Winiger; Eileen Chun; Elke Schipani; Abigail Kalmbach; Joseph F Cheer; Peter D Balsam; Eleanor H Simpson
Journal:  J Neurosci       Date:  2018-01-24       Impact factor: 6.167

4.  Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction.

Authors:  Jen-Hau Yang; Rose E Presby; Adam A Jarvie; Renee A Rotolo; R Holly Fitch; Mercè Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2019-08-08       Impact factor: 4.530

5.  Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.

Authors:  Renee A Rotolo; Predrag Kalaba; Vladimir Dragacevic; Rose E Presby; Julia Neri; Emily Robertson; Jen-Hau Yang; Merce Correa; Vasiliy Bakulev; Natalia N Volkova; Christian Pifl; Gert Lubec; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2020-08-07       Impact factor: 4.530

Review 6.  Molecular insights into the therapeutic promise of targeting HMGB1 in depression.

Authors:  Tarapati Rana; Tapan Behl; Vineet Mehta; Md Sahab Uddin; Simona Bungau
Journal:  Pharmacol Rep       Date:  2020-10-04       Impact factor: 3.024

Review 7.  The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation.

Authors:  John D Salamone; Mercè Correa; Sarah Ferrigno; Jen-Hau Yang; Renee A Rotolo; Rose E Presby
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

8.  Central oxytocin signaling inhibits food reward-motivated behaviors and VTA dopamine responses to food-predictive cues in male rats.

Authors:  Clarissa M Liu; Ted M Hsu; Andrea N Suarez; Keshav S Subramanian; Ryan A Fatemi; Alyssa M Cortella; Emily E Noble; Mitchell F Roitman; Scott E Kanoski
Journal:  Horm Behav       Date:  2020-10-01       Impact factor: 3.587

9.  Noradrenergic But Not Dopaminergic Neurons Signal Task State Changes and Predict Reengagement After a Failure.

Authors:  Caroline I Jahn; Chiara Varazzani; Jérôme Sallet; Mark E Walton; Sébastien Bouret
Journal:  Cereb Cortex       Date:  2020-07-30       Impact factor: 5.357

10.  Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning.

Authors:  Heather E Soder; Jessica A Cooper; Paula Lopez-Gamundi; Jennifer K Hoots; Cecilia Nunez; Victoria M Lawlor; Scott D Lane; Michael T Treadway; Margaret C Wardle
Journal:  Neuropsychopharmacology       Date:  2020-07-28       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.